Clinical trial NCT05211895 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2030-10-01 → 2027-09-08 3. primary completion date: 2028-07-12 → 2026-08-10 4. enrollment: 860 → 791 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07357831 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. start date: 2025-12-26 → 2025-12-30 3. completion date: 2026-12-17 → 2026-08-19 4. primary completion date: 2026-10-10 → 2026-08-06 5. enrollment: 537 → 539 participants 6. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07030517: completion date: 2027-06-20 → 2027-02-14.
Clinical trial NCT07654751 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-10-01 → 2026-08-07
Clinical trial NCT04577833: completion date: 2026-12-31 → 2027-12-31.
Clinical trial NCT07589634: completion date: 2030-12-02 → 2030-11-08.
Clinical trial NCT00781612 updates: 1. completion date: 2026-11-28 → 2027-06-30 2. primary completion date: 2026-10-31 → 2027-06-30
Clinical trial NCT07609225 updates: 1. start date: 2026-08-01 → 2026-09-01 2. completion date: 2029-08-01 → 2029-09-01 3. primary completion date: 2029-08-01 → 2029-09-01
Clinical trial NCT04557059: enrollment: 692 → 691 participants.
Clinical trial NCT07577856: completion date: 2030-10-30 → 2030-10-16.
Clinical trial NCT07582809 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-07-20
Clinical trial NCT07604545 updates: 1. status: NOT_YET_RECRUITING → WITHDRAWN 2. enrollment: 554 → 0 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05702034 updates: 1. completion date: 2026-12-09 → 2026-10-15 2. primary completion date: 2026-11-11 → 2026-10-15 3. enrollment: 12532 → 12523 participants
Clinical trial NCT05421663: primary completion date: 2028-12-29 → 2041-07-30.
Clinical trial NCT06120283 updates: 1. completion date: 2028-11-01 → 2029-12-01 2. primary completion date: 2028-11-01 → 2029-12-01 3. enrollment: 399 → 433 participants